A combined effect of immune checkpoint inhibitors and a CD40 agonistic antibody in a pancreatic cancer mouse model

被引：0
|
作者：
Ichikawa, Juri [1 ]
Kawano, Kuniyuki [1 ,2 ]
Kato, Shingo [1 ,3 ]
Kurotaki, Daisuke [1 ,4 ]
Kuroishikawa, Ryo [1 ]
Kawase, Wataru [1 ,5 ]
Yoshida, Haruka [1 ]
Hiroshima, Yukihiko [5 ]
Endo, Itaru [6 ]
Maeda, Shin [2 ]
Nakajima, Atsushi [3 ]
Tamura, Tomohiko [1 ]
机构：
[1] Yokohama City Univ, Dept Immunol, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Gastroenterol, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan
[4] Kumamoto Univ, Lab Chromatin Org Immune Cell Dev, Kumamoto, Japan
[5] Kanagawa Canc Ctr, Res Inst, Ctr Canc Genome Med, Yokohama, Kanagawa, Japan
[6] Yokohama City Univ, Dept Gastrol Surg, Yokohama, Kanagawa, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2009
引用
收藏
页码：763 / 763
页数：1
相关论文
共 50 条
  • [41] Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model
    Murakami, Kazuyuki
    Yoshino, Naoto
    Kawamura, Hanae
    Sasaki, Yutaka
    Kagabu, Masahiro
    Muraki, Yasushi
    Sugiyama, Toru
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2015, 112 : 139 - 139
  • [42] Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
    Yang Liu
    Yinping Dong
    Li Kong
    Fang Shi
    Hui Zhu
    Jinming Yu
    Journal of Hematology & Oncology, 11
  • [43] Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
    Liu, Yang
    Dong, Yinping
    Kong, Li
    Shi, Fang
    Zhu, Hui
    Yu, Jinming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [44] Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
    Liu, Hsuan-Chen
    Davila Gonzalez, Daniel
    Viswanath, Dixita Ishani
    Vander Pol, Robin Shae
    Saunders, Shani Zakiya
    Di Trani, Nicola
    Xu, Yitian
    Zheng, Junjun
    Chen, Shu-Hsia
    Chua, Corrine Ying Xuan
    Grattoni, Alessandro
    ADVANCED SCIENCE, 2023, 10 (09)
  • [45] The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
    Meltzer, Sebastian
    Torgunrud, Annette
    Abrahamsson, Hanna
    Solbakken, Arne Mide
    Flatmark, Kjersti
    Dueland, Svein
    Bakke, Kine Mari
    Bousquet, Paula Anna
    Negard, Anne
    Johansen, Christin
    Lyckander, Lars Gustav
    Larsen, Finn Ole
    Schou, Jakob Vasehus
    Redalen, Kathrine Roe
    Ree, Anne Hansen
    BRITISH JOURNAL OF CANCER, 2021, 125 (02) : 240 - 246
  • [46] A potent adjuvant effect of CD40 antibody attached to antigen
    Barr, TA
    McCormick, AL
    Carlring, J
    Heath, AW
    IMMUNOLOGY, 2003, 109 (01) : 87 - 92
  • [47] The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
    Sebastian Meltzer
    Annette Torgunrud
    Hanna Abrahamsson
    Arne Mide Solbakken
    Kjersti Flatmark
    Svein Dueland
    Kine Mari Bakke
    Paula Anna Bousquet
    Anne Negård
    Christin Johansen
    Lars Gustav Lyckander
    Finn Ole Larsen
    Jakob Vasehus Schou
    Kathrine Røe Redalen
    Anne Hansen Ree
    British Journal of Cancer, 2021, 125 : 240 - 246
  • [48] Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
    Xiao, Fen
    Wang, Zhibin
    Qiao, Liu
    Zhang, Xiu
    Wu, Nayiyuan
    Wang, Jing
    Yu, Xing
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [49] Gastrin vaccine and immune checkpoint antibody therapy for pancreatic cancer
    Smith, Jill P.
    Osborne, Nicholas
    Sundseth, Rebecca
    Burks, Julian
    Cao, Hong
    Liu, Xunxian H.
    Kroemer, Alexander H.
    Sutton, Lynda Youngpeter
    Cato, Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [50] Celecoxib and chloroquine enhance the antitumor effect of immune checkpoint blockade therapy, in a syngeneic mouse model for pancreatic cancer
    Moore, Jaeger
    Chand, Dhan
    Levey, Daniel
    Von Hoff, Daniel
    Han, Haiyong
    CANCER RESEARCH, 2024, 84 (06)
12345